Clinical Trials on pMMR
Total 54 results
-
China Medical University, ChinaRecruitingMetastatic Colorectal Adenocarcinoma | MSS | pMMRChina
-
The Netherlands Cancer InstituteAgenus Inc.RecruitingResectable MMR-deficient Solid Tumors | Resectable MMR-proficient Solid TumorsNetherlands
-
Rutgers, The State University of New JerseyCompletedMBSR-STEM | PMR-STEM | MBSR-NON-STEM | PMR -NON-STEMUnited States
-
xunaRecruiting
-
Serum Institute of India Pvt. Ltd.PATHCompletedImmune Response to MMR VaccineIndia
-
Albert Einstein College of MedicineTerminatedCancer | Solid Tumor | Metastatic Solid Tumor | Metastatic dMMR Solid CancerUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruiting
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
BeiGeneRecruitingMSI-H/dMMR Solid TumorsChina
-
AkesoAkeso Pharmaceuticals, Inc.TerminatedMSI-H/dMMR Solid TumorChina
-
Servier Bio-Innovation LLCMerck Sharp & Dohme LLC; Institut de Recherches Internationales ServierNot yet recruitingMSI-H/dMMR Gastroesophageal-junction Cancer | MSI-H/dMMR Gastric Cancer
-
Peking University Cancer Hospital & InstituteRecruiting
-
Second Affiliated Hospital, School of Medicine,...Shanghai Junshi Bioscience Co., Ltd.; Qilu Pharmaceutical Co., Ltd.UnknownMSS | pMMR | Refractory Metastatic Colorectal CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownMSI-H or dMMR Advanced Solid TumorsChina
-
Mayo ClinicChildren's Hospital of Philadelphia; Seattle Children's HospitalTerminated
-
Zhejiang UniversityRecruitingMSS | Locally Advanced Rectal Carcinoma | pMMR | MSI-LChina
-
Federation Francophone de Cancerologie DigestiveRecruitingMetastatic Colorectal Cancer | MSS | pMMR | Immune Checkpoint Inhibitor | Internal RadiotherapyFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMSI | dMMR Colorectal CancerFrance
-
Replimune Inc.Roche Pharma AGActive, not recruitingMSS | pMMR | Refractory Metastatic Colorectal CancerUnited States
-
Yunnan Cancer HospitalBeijing Bethune Charitable FoundationRecruitingEnvafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal CancerChina
-
Maggie's Pearl, LLCActive, not recruitingPmm2-CDG | Phosphomannomutase 2 Deficiency | Phosphomannomutase 2 Congenital Disorder of Glycosylation | Phosphomannomutase II Congenital Disorder of Glycosylation | Phosphomannomutase II DeficiencyUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutatedChina
-
University of UtahElevar TherapeuticsTerminatedUrothelial Carcinoma | Advanced Malignancies | Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | MSI-H or dMMR Solid TumorsUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Bristol-Myers SquibbRecruitingLocalized Oesogastric Adenocarcimona | MSI and or dMMRFrance
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
University of IowaRecruitingColon Cancer | dMMR Colorectal CancerUnited States
-
Second Affiliated Hospital, School of Medicine,...Changxing People's HospitalRecruitingUnresectable Colon Cancer Peritoneal Metastases | PMMR/Ras/BRAF Wild-typeChina
-
Centre Leon BerardActive, not recruitingLocalized Resectable Tumor | MSI/dMMR or EBV-positive Gastric CancersFrance
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Sun Yat-sen UniversityActive, not recruitingDMMR Colorectal Cancer | MSI-H Colorectal Cancer | Locally Advanced Colorectal CancerChina
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Sun Yat-sen UniversityRecruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaboratorsRecruitingRectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr DeficiencyChina
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Spain, Singapore, Belgium, Germany, Korea, Republic of, Taiwan, France, Israel, United States
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage II | Colorectal Cancer Stage III | MSI-H | Mmr DeficiencyChina
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Peking UniversityNot yet recruitingMSI-H/dMMR Gastric Carcinoma and Colorectal Cancer
-
University of MichiganCompletedMeasles | Rubella | Mumps | MMR VaccinationUnited States
-
Children's National Research InstitutePfizerCompletedImmunization | Hepatitis B Vaccine | Poliovirus Vaccine, Inactivated | DTaP Vaccine | MMR Vaccine | HIB-vaccine | Chickenpox Vaccine | Pneumococcal Polysaccharide Vaccine
-
University Hospital, BrestEli Lilly and CompanyCompletedPolymyalgia Rheumatic (PMR)France
-
Hospital for Special Surgery, New YorkGenentech, Inc.Completed
-
University Hospital, Basel, SwitzerlandNovartis; Schweizerische Stiftung für die Erforschung der MuskelkrankheitenRecruitingPolymyalgia Rheumatica (PMR) | Giant Cell Arteritis (GCA)Switzerland
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
Incyte CorporationRecruitingMelanoma | Hepatocellular Carcinoma (HCC) | Renal Cell Carcinoma (RCC) | Colorectal Carcinoma (CRC) | Microsatellite Instability - High (MSI-H) | Mismatch Repair Deficient (dMMR)United States, Brazil, Canada, Australia, Slovakia, Sweden, Norway, Mexico
-
Incyte CorporationCompletedMelanoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer) | MMR-deficient TumorsUnited States
-
Massachusetts General HospitalRecruitingLynch Syndrome | Genetic Predisposition to Disease | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Neoplasm | ATM Gene Mutation | MMR MutationUnited States
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditionsUnited States, Australia, Korea, Republic of, Canada